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Effects of Feeding OmniGen-AF® on Immune Function,
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Joe O. Buntyn, Sara E. Sieren, Curtis J. Bittner, Dirk B. Burken, Galen E. Erickson, Nicole C. Burdick Sanchez,
Jeff A. Carroll, Steve J. Jones, Ty B. Schmidt, Kevin C. Dehann and Troy J. Wistuba

Summary

Procedures

OmniGen-AF (Phibro Animal Health,
Quincy, IL) was fed to steers to evaluate
the effects on the metabolic and immune
response during an immune challenge, as
well as feedlot performance. The inclusion of
OmniGen-AF for either the first 28 d or the
entire feeding period) did not impact feedlot
performance or carcass characteristics. However, within a subset of cattle receiving an
immune challenge (the endotoxin lipopolysaacharide; LPS), OmniGen-AF supplementation did alter the metabolic and immune
profile of steers. These results suggest that
feeding of OmniGen-AF may enhance the
metabolic and immune response if cattle are
challenged by bovine respiratory disease.

Three hundred and six calf-fed steers
(BW 581 ± 41 lb) were utilized in a randomized block design experiment at the
University of Nebraska-Lincoln Agricultural Research and Development Center
(ARDC) near Mead, Neb. Steers were
received over two d period at the ARDC.
Upon arrival, steers were provided access
to water and were processed, weighed, and
allocated to treatment within 12 hours.
Steers were blocked based on arrival date
resulting in two blocks. Within blocks,
steers were assigned randomly to 36 pens
and pens assigned randomly to treatment
(8–9 steers/pen and 12 pens/treatment).
Treatments diets included: Control
(CON; basal receiving diet, no OmniGenAF); basal receiving diet with OmniGenAF supplemented at 4 g/100 cwt/hd/d
for the first 28 d on feed (OG+28); or
OmniGen-AF supplemented at 4 g/
cwt/hd/d for the entire feeding period
(OG+EFP). OmniGen-AF was supplemented daily to steers through the diet
supplement for—both OmniGen treatment
groups. The receiving diet was 30% alfalfa
hay, 30% dry rolled corn, and 36% Sweet
Bran with 4% supplement added. After
the receiving period, steers were limit-fed
a diet (50% alfalfa hay, 50% Sweet Bran)
at 2% of BW for 5 d before weighing for
ending BW to minimize gut fill variation.
Ending BW for the receiving period was
an average of 2 d weights collected after
limit-feeding. Steers were adapted to a
common finishing diet by replacing alfalfa
hay at 27.5%, 20%, 12.5%, 5%, and 0% with
high moisture corn at 22.5%, 30%, 37.5%,
45%, and 50% of the diet DM for steps 1
through 5 of the ration. Sweet Bran was
held constant 40% while wheat straw and
supplement were both held constant at 5%.
During the adaptation, heifers were on
step 1 for three d, step 2 for four d, step 3
for seven d, step 4 for seven d, and step 5

Introduction
Within the beef industry, one of the
most prevalent diseases is Bovine Respiratory Disease (BRD). The major hurdle
in overcoming BRD is the multi-factorial
etiology of the disease. Bovine respiratory
disease is a combination of stress, viral
pathogens, and bacterial pathogens that interact to cause major economic losses due
to morbid cattle. A potential strategy to aid
in combating BRD could be the inclusion
of OmniGen-AF. OmniGen-AF is a feed
additive that is composed of active dried
Saccharomyces cerevisiae in combination
with other vitamins and minerals that may
have the potential to enhance the immune
function of cattle. OmniGen-AF is a patented proprietary product shown to augment the innate immune function in cattle.
The purpose of this study was to evaluate
differences in immune response, feedlot
performance, and carcass merit of newly
received calf-fed steers fed OmniGen-AF.
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was the finishing ration. The final finishing
diet included 50% high moisture corn,
40% Sweet Bran, 5% wheat straw, and 5%
supplement. At the conclusion of the 28 d
receiving period, OmniGen+28 steers were
switched to the CON diet (no OmniGenAF), while OmniGen+EFP cattle continued to receive OmniGen-AF supplement;
recalculated every 30 d to supply 4 g/cwt/
hd/d of BW. Also, after the 28 d receiving
period, all steers were implanted with
Revalor® XS (Merck). During the last 28 d
of the finishing period, all cattle were supplemented Optaflexx® (Elanco) for 28 d at
300 mg/hd/d. At the end of the trial, steers
were transported to Greater Omaha Pack
(Omaha, Neb.). The following morning
steers were harvested at which time hot
carcass weights (HCW) were recorded.
Following a 48 h chill, fat thickness, rib
eye area (REA), and USDA marbling score
were determined. Final BW, ADG, and F:G
were calculated using HCW adjusted to a
common (63%) dressing percentage.
To evaluate the immune response,
on d 25 of the receiving period, 18 steers
(nine steers from CON (n = 9), and
OmniGen-AF treatment groups (n = 9;
4 from OmniGen+28 and 5 from OmniGen+EFFP) treatment groups) from block
2 were randomly selected for an immune
challenge and moved into a tie stall barn.
After a 3 d adjustment period, steers were
fitted with indwelling jugular vein catheters
for serial blood collection and indwelling
rectal temperature (RT) recording devices,
programed to record RT at 5-min intervals. After insertion of the jugular catheter
and RT device, steers were returned to the
individual tie stalls and allowed to rest for
the remainder of the d.
On the following d, from 0800 to 1800
h, blood samples were collected at 30 min
intervals from 2 h prior to the challenge to
8 h after the challenge. At 1000 (0 h), following the collection of the blood sample,
steers were administered an i.v. bolus of

lipopolysaccharide (LPS, 0.5 μg/kg BW; E.
coli O111:B4). At each collection point, 9
mL of blood was collected via monovette
tubes for serum. After collection, blood
samples were allowed to clot for 30 min at
room temperature, centrifuged at 2,000 x
g for 30 min (39.2°F) and serum was separated. Serum was collected and transferred
into 1.5 mL microcentrifuge tubes and held
at-112ºF until analyzed for cortisol, proinflammatory cytokines (Tumor Necrosis
Factor-α; TNF-α, Interferon-γ; IFN-γ, and
Interleukin-6; IL-6), blood urea nitrogen
(BUN), non-esterified fatty acids (NEFA),
and glucose.
Feedlot performance data were analyzed as a randomized block design using
MIXED procedures of SAS (SAS Institute,
Inc., Cary, NC). Steers were blocked by
arrival date and pen was the experimental
unit; model included the fixed effect of
treatment and block was a random effect.
Immune response data were analyzed as a
completely randomized design with repeated measures using the MIXED procedures
of SAS; model included fixed effects of
treatment and time, treatment × time was
used as the error term to test whole plot
effect. For both feedlot and immune data,
when results of F-test were significant (P
< 0.05), group means were compared by
use of least significant difference. Pair wise
differences among least squares means at
various sample times were evaluated with
the PDIFF option of SAS. Distribution of
USDA Quality Grade data were analyzed
as a randomized block design using the
GLIMMIX procedure of SAS.

or USDA Select Quality Grades for all three
dietary treatments. These data suggest that
including OmniGen-AF during the receiving period (28 d) or for the entire feeding
period does not impact feedlot performance or carcass merit of calf-fed steers.
For the LPS challenge portion of the
trial, there was a dietary treatment (P
= 0.002) and time effect (P = < 0.001);
however, there was no dietary treatment x
time interaction (P = 0.99) for RT. Steers
within the OmniGen-AF treatment groups
had a greater (P < 0.01) RT when compared
to CON steers (102.70 ± 0.02°F vs. 102.51
± 0.02°F, respectively). For both groups of
steers, maximum RT was observed 2.5 h
post LPS administration, and within 6 h,
RT had returned to baseline temperatures
(Figure 1.). Prior to the LPS challenge, RT

Table 1. Receiving period and overall feedlot performance and carcass merit for steers
fed no OmniGen-AF (CON), OmniGen-AF during the receiving period (OmniGen+28),
or OmniGen-AF for 215 d (OmniGen+EFP)
Treatment groupsa

Item

SEM

P-value

CON

OmniGen 28

OmniGenEFP

571

573

577

7.0

0.82

662

670

675

8.0

0.43

0.80

0.76

0.33

0.32

Receiving Performance
Initial BW, lb
b

Ending BW, lb
DMI, lb/d
ADG, lb

16.5

c

17.0

16.8

3.18

3.38

3.48

Feed:Gain

5.53

5.00

5.24

Morbidity, %e

6.9

2.0

3.0

d

—

0.35

3.0

0.12

Feedlot Performance
Initial BW, lb

662

670

675

6.0

0.87

Final BW, lbf

1431

1416

1417

11.0

0.59

0.3

0.89

DMI lb/d

21.6
g

Results
At the conclusion of the receiving
period (28 d), ending BW (P = 0.43), DMI
(P = 0.76), ADG (P = 0.32), and F:G (P
= 0.35) were similar between treatments.
While overall rate of morbidity was low,
there was a trend (P = 0.12) for morbidity to be decreased in OmniGen+28 and
OmniGen+EFP steers when compared
to CON steers. At the conclusion of the
finishing period, no difference in final
BW (P = 0.59), DMI (P = 0.89), ADG (P
= 0.66) or F:G (P = 0.90) were observed
across the three dietary treatments (Table
1). In regards to carcass merit, there were
no differences in weight or characteristics
(P > 0.31). There was no difference in the
percentage of USDA Prime, USDA Choice,

was greater in the OmniGen-AF steers
when compared to CON steers. Due to this
difference prior to challenge, RT data were
analyzed as the change in RT from baseline.
As a change from baseline, RT was similar
(P = 0.49) between the treatment groups.
For serum concentrations of cortisol,
there was a dietary treatment effect (P =
0.005) whereby OmniGen-AF steers had
decreased cortisol concentrations when
compared to the CON steers (Table 2).
Cortisol is the primary hormone responsible for the stress response. During an
immune challenge, aside for initiating the
bodies response to the stress (immune
challenge) the release of cortisol also serves
to prevent hyper-inflammation. There was
a dietary treatment effect (P = 0.03) for
the pro-inflammatory cytokines TNF-α

21.6

21.8

ADG lb/d

3.91

3.92

3.93

0.04

0.66

Feed:Gain

5.55

5.51

5.56

—

0.90

7.0

0.96

Carcass Merit
HCW, lb
LM area, in

901
2

Calculated YG
12th rib fat, in.
Marblingh

892

893

14.7

14.2

14.6

0.25

0.31

3.1

3.3

3.1

0.14

0.52

0.5
503

0.6
498

0.6
508

0.14
24.0

0.86
0.96

Prime (%)

4.5

2.1

5.3

2.32

0.53

Choice (%)

76.4

76.6

81.9

4.50

0.59

Select (%)

19.1

21.3

13.8

4.22

0.41

a

CON: No OmniGen-AF; OMN-28: OmniGen-AF during receiving, OMN-EFP: OmniGen for 215 d (the entire feeding
period).
Limit fed at 2% of BW for 4 d prior to single BW to determine ending BW of receiving period
c
Calculated from ending BW of receiving period
d
Analyzed as G:F, the reciprocal of F:G.
e
Overall percentage of steers treated for bovine respiratory disease
f
Calculated from carcass weight, adjusted to 63% common dressing percent.
g
ADG for the entire feeding period (including receiving period)
h
Marbling Score: 400 = Small, 500 = Modest, etc.
b
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and immune response of calf-fed steers
during an LPS challenge. While there was
a decreased rate of morbidity in both treatments, the trend in decreased receiving
morbidity in the OmniGen-AF fed steers
may be a result of the alterations observed
in the LPS challenge (decreased energy metabolism and increased pro-inflammatory
cytokines). Overall, these alterations
associated with OmniGen-AF feeding
may allow for an enhanced metabolic and
immune response of newly received cattle,
which may help cattle combat BRD.

106
CON
OmniGen

105

Rectal Temperature (°F)

104

103

102

101

100

99

Joe O. Buntyn, graduate student
Treatment
Time
Treatment x Time
SEM

Overall
= 0.002
= <0.001
= 0.99
= 0.125

Prior
= <0.001
= <0.001
= 0.99

Sara E. Sieren, graduate student

Post
= 0.82
= <0.001
= 0.99

Curtis J. Bittner, research technician
Dirk B. Burken, research technician
Galen E. Erickson, professor, University of
Nebraska—Lincoln (UNL) Department of
Animal Science, Lincoln, Neb.

98
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Time (h) relative to LPS challenge
Figure 1. Rectal temperature of newly received steers supplemented OmniGen-AF at a rate of 4 g/cwt/hd/d
(OmniGen) during the receiving period (28 d) or no OmniGen-AF (CON) during a lipopolysaccharide
challenge

and IFN-γ (Table 2). Concentrations of
TNF-α and IFN-γ were greater (P = 0.03)
in OmniGen-AF steers when compared
to the CON steers. Concentrations of IL-6
were not impacted (P = 0.87) by dietary
treatment. Pro-inflammatory cytokines are
released as a first response to an immune
challenge; initiating a cascade of the
immune response, such as inducing fever,
inflammation, and initiating the healing
of damaged tissue. The increased production of TNF-α and IFN-γ, may indicate
the OmniGen-AF fed steers were able to
mount a more robust pro-inflammatory
response, compared to the CON steers.
Blood urea nitrogen (BUN), nonesterified fatty acids, and glucose were
analyzed to evaluate metabolic alterations
during the LPS challenge. Steers within
the CON treatment group had greater (P
< 0.01) concentrations of BUN and NEFA
when compared to the OmniGen-AF steers
(Table 2). Serum glucose concentrations
were greater (P < 0.01) for OmniGen-AF
fed steers, when compared to CON steers
(76.42 ± 1.1 mg/mL vs. 72.42 ± mg/mL, respectively; Table 2). Both BUN and NEFA
are indicators of energy mobilization; this
increase in both BUN and NEFA may indicate a greater need for energy from CON
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steers to mount an immune response when
compared to OmniGen-AF steers.
Overall, the results of this study indicate
that the feeding of OmniGen-AF to calf-fed
steers did not impact feedlot performance
or carcass merit, but did alter the metabolic

Nicole C. Burdick Sanchez
Jeff A. Carroll, USDA ARS, Lubbock TX
Steve J. Jones, professor
Ty B. Schmidt, assistant professor, University of Nebraska–Lincoln (UNL) Department of Animal Science, Lincoln, Neb.
Kevin C. Dehann, Phibro Animal Health,
Quincy, IL
Troy J. Wistuba, Phibro Animal Health,
Quincy, IL

Table 2. Endocrine, immune, and metabolic analysis of newly received steers supplemented
OmniGen-AF at a rate of 4 g/cwt (OMN) during the receiving period (28 d)
or no OmniGen-AF (CON) during a lipopolysaccharide challenge (LPS)
Treatment groupsa
CON

Trt

Time

T×T

Overall Cortisol

29.22

25.52

4.44

0.05

< 0.001

0.99

Post-LPSb

34.74

30.07

1.15

0.004

< 0.001

0.99

Overall TNF–αc

12.85

25.94

3.97

0.03

< 0.001

0.42

Post-LPS

15.71

31.04

4.88

0.03

< 0.001

0.47

Overall IFN–γ

d

0.76

1.85

0.21

0.003

< 0.001

0.77

Post-LPS

0.93

2.12

0.26

0.007

< 0.001

0.81

e

1877.66

1849.28

697.75

0.87

< 0.001

0.99

Overall BUNf

12.44

11.47

0.12

< 0.001

0.28

0.99

Overall NEFAg

0.21

0.10

0.01

0.002

< 0.001

0.49

Overall Glucose

72.42

76.36

1.12

0.009

< 0.001

0.19

Post-LPS

69.72

74.23

1.28

0.009

< 0.001

0.23

Overall IL-6

a

SEM

OmniGen

CON = basal receiving diet (No OmniGen), OmniGen = OmniGen-AF at a rate of 4 g/cwt for 28 d. For the OmniGen treatment group; 4 steers from the OmniGen+28 group and 5 steers from the OmniGen+EFP were utilized)
b
Treatment means after the LPS challenge (0.5–24 h)
c
Tumor necrosis-α
d
Interferon-γ
e
Interleukin-6
f
Blood urea nitrogen
g
Non-esterified fatty acids

